Monday, January 27, 2020

Vyera Responds to U.S. Federal Trade Commission Civil Action Related to Daraprim®

NEW YORK, Jan. 27, 2020 /PRNewswire/ -- Vyera Pharmaceuticals, LLC (Vyera) acknowledges the decision announced today by the U.S. Federal Trade Commission ("FTC") and the New York State Office of the Attorney General ("NYAG") to file a civil action against Vyera, its parent company, and...



from PR Newswire: https://ift.tt/3aNYOJK

No comments:

Post a Comment